Sofinnova Investments as of March 31, 2023
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 51 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 20.6 | $322M | 1.8M | 181.64 | |
| Natera (NTRA) | 11.0 | $172M | 3.1M | 55.52 | |
| Merck & Co (MRK) | 5.7 | $90M | 842k | 106.39 | |
| SPDR S&P 500 ETF Trust Tr Unit Put Option (SPY) | 5.2 | $82M | 200k | 409.39 | |
| Ascendis Pharma A/S Sponsored Adr (ASND) | 5.2 | $81M | 754k | 107.22 | |
| Aerovate Therapeutics (AVTE) | 4.8 | $76M | 3.8M | 20.17 | |
| Reata Pharmaceuticals Cl A | 3.6 | $57M | 628k | 90.92 | |
| Eli Lilly & Co. (LLY) | 3.0 | $47M | 137k | 343.42 | |
| Horizon Therapeutics SHS | 2.9 | $45M | 409k | 109.14 | |
| Intuitive Surgical (ISRG) | 2.4 | $38M | 150k | 255.47 | |
| Biogen Idec (BIIB) | 2.4 | $37M | 133k | 278.03 | |
| BioMarin Pharmaceutical (BMRN) | 2.2 | $35M | 359k | 97.24 | |
| Dex (DXCM) | 1.9 | $30M | 257k | 116.18 | |
| Travere Therapeutics (TVTX) | 1.8 | $28M | 1.3M | 22.49 | |
| Vera Therapeutics Cl A (VERA) | 1.7 | $27M | 3.5M | 7.76 | |
| Ptc Therapeutics I (PTCT) | 1.6 | $25M | 517k | 48.44 | |
| Zentalis Pharmaceuticals (ZNTL) | 1.6 | $25M | 1.4M | 17.20 | |
| Inhibrx | 1.5 | $24M | 1.2M | 18.87 | |
| Chinook Therapeutics | 1.5 | $23M | 1.0M | 23.15 | |
| Syndax Pharmaceuticals (SNDX) | 1.5 | $23M | 1.1M | 21.12 | |
| Iveric Bio | 1.4 | $22M | 906k | 24.33 | |
| Immatics NV SHS (IMTX) | 1.4 | $22M | 3.1M | 6.90 | |
| Inozyme Pharma (INZY) | 1.3 | $21M | 3.7M | 5.73 | |
| Geron Corporation (GERN) | 1.1 | $18M | 8.3M | 2.17 | |
| Sarepta Therapeutics (SRPT) | 1.0 | $16M | 119k | 137.83 | |
| Exelixis (EXEL) | 1.0 | $16M | 831k | 19.41 | |
| Vir Biotechnology (VIR) | 1.0 | $15M | 658k | 23.27 | |
| Celldex Therapeutics (CLDX) | 1.0 | $15M | 419k | 35.98 | |
| Prometheus Biosciences | 0.9 | $13M | 124k | 107.32 | |
| Cytokinetics (CYTK) | 0.8 | $13M | 354k | 35.19 | |
| Cti Biopharma | 0.8 | $12M | 2.8M | 4.20 | |
| Y Mabs Therapeutics | 0.7 | $11M | 2.2M | 5.01 | |
| Agenus | 0.6 | $9.7M | 6.4M | 1.52 | |
| Marinus Pharmaceuticals | 0.5 | $8.3M | 1.2M | 6.90 | |
| Galera Therapeutics (GRTX) | 0.5 | $7.9M | 3.1M | 2.56 | |
| Kura Oncology (KURA) | 0.5 | $7.5M | 616k | 12.23 | |
| Axsome Therapeutics (AXSM) | 0.5 | $7.5M | 121k | 61.68 | |
| ImmunoGen Call Option | 0.5 | $7.4M | 1.9M | 3.84 | |
| Ideaya Biosciences (IDYA) | 0.4 | $6.2M | 453k | 13.73 | |
| Nucana Sponsored Adr | 0.3 | $5.4M | 5.6M | 0.96 | |
| Revolution Medicines (RVMD) | 0.3 | $4.0M | 184k | 21.66 | |
| Nextcure (NXTC) | 0.3 | $4.0M | 2.7M | 1.48 | |
| Bolt Biotherapeutics | 0.2 | $3.8M | 2.8M | 1.39 | |
| Keros Therapeutics (KROS) | 0.2 | $3.3M | 77k | 42.70 | |
| Novocure Ord Shs Call Option (NVCR) | 0.2 | $3.0M | 50k | 60.14 | |
| Nucana Common Shares | 0.1 | $2.3M | 2.4M | 0.96 | |
| Bluebird Bio | 0.1 | $2.1M | 673k | 3.18 | |
| Pds Biotechnology Ord (PDSB) | 0.1 | $877k | 143k | 6.15 | |
| Fusion Pharmaceuticals | 0.0 | $442k | 117k | 3.77 | |
| Synlogic | 0.0 | $363k | 575k | 0.63 | |
| Alnylam Pharmaceuticals (ALNY) | 0.0 | $90k | 448.00 | 200.32 |
